ArticleActa paediatrica (Oslo, Norway : 1992)2026
Improving Medication Safety Following Neonatal Discharge: A Feasibility Study of a Parent Medication Education Intervention in Ireland.
Article in Acta paediatrica (Oslo, Norway : 1992), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
aimNeonates discharged home on medications remain at risk of medication errors. The PADDINGToN programme previously developed parent co-designed resources to support safer medication administration following discharge. The aim of this study, PADDINGToN-2, is to evaluate the feasibility of recruiting and retaining parents in a study assessing these resources in order to support safer medication administration at home.
methodsProspective single-centre feasibility study in a level 3 neonatal unit between March and December 2025. Parents of infants discharged on ≥ 2 medications were recruited before discharge, and followed for 12 weeks. Primary outcome was recruitment and retention using predefined progression criteria. Secondary outcomes included assessment of parental anxiety and confidence in medication administration.
resultsIn all, 35 parents were recruited. Retention was 42.8%, meeting predefined 'Amber' progression criteria indicating feasibility with protocol modification. Anxiety scores decreased from a median of 9 at baseline to 5 at follow-up.
conclusionsRecruitment was feasible, and retention met predefined criteria, supporting progression to a larger multi-centre implementation study with optimised retention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.